2024-11-18 19:26:49
ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma
Corporate/ 2023-07-23
ASH 2019 | CStone's anti-PD-L1 anti...

SUZHOU,China,Nov. 7,2019-- CStone Pharmaceuticals ("CStone" or the "Company",HKEX: 2616) today announced that an abstrac...

Bactiguard Holding AB (publ): Interim Report for Q3 2019
Corporate/ 2023-07-23
Bactiguard Holding AB (publ): Interim Re...

STOCKHOLM,Nov. 7,2019-- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bact...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release